Icon

TRIKAFTA (COPACKAGED) (nda212273)- (50MG,37.5MG,25MG; 75MG,100MG,75MG,50MG; 150MG)

ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR VERTEX PHARMS INC
50MG,37.5MG,25MG; 75MG,100MG,75MG,50MG; 150MG
No No
2037-Dec-08 2024-Oct-21
None None
None No
TRIKAFTA is a combination of ivacaftor, a CFTR potentiator, tezacaftor, and elexacaftor indicated for the treatment of cystic fibrosis (CF) in patients aged 6 years and older who have at least one F508del mutation in the CFTR gene or a mutation in the CFTR gene that is responsive based on in vitro data.
0 0 0
Total Other Developers None
Drugs with Suitability No
50MG,37.5MG,25MG; 75MG ** ** - - -
100MG,75MG,50MG; 150MG ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.